Tolvaptan in euvolemic hyponatremia ( DrugBank: Tolvaptan )


1 disease
IDDisease name (Link within this page)Number of trials
72Pituitary ADH secretion disorder1

72. Pituitary ADH secretion disorder


Clinical trials : 41 Drugs : 27 - (DrugBank : 8) / Drug target genes : 7 - Drug target pathways : 10
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01425125
(ClinicalTrials.gov)
November 201125/8/2011Fractional Urate Excretion in Nonedematous HyponatremiaStudy of Nonedematous Hyponatremia and the Utility of Fractional Urate Excretion in Hyponatremia and Suspected Renal Salt Wasting Without Hyponatremia-Cerebral Hyponatremia;SIADH;Cerebral Salt-wasting Syndrome;Reset Hypothalamic OsmostatDrug: Tolvaptan in euvolemic hyponatremiaNYU Langone HealthNULLWithdrawn18 YearsN/AAll0N/AUnited States